대장균 균주 시장 : 균주 유형별, 용도별, 병원성별, 최종사용자별, 지역별

Escherichia Coli Strain Market is estimated to be valued at USD 2.26 Bn in 2025 and is expected to reach USD 3.61 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.

Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.

Market Dynamics:

Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.

However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global escherichia coli strain market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market

Detailed Segmentation:

• Escherichia Coli Strain Market, By Strain Type:
  • Commensal strains
  • Diarrheal strains
  • Extraintestinal pathogenic strains
  • Uropathogenic strains
  • Neonatal meningitis strains
  • Others
• Escherichia Coli Strain Market, By Application:
  • Diagnostics
  • Research
  • Therapeutics
  • Production of recombinant proteins
  • Quality control organisms
  • Others
• Escherichia Coli Strain Market, By Pathogenicity:
  • Pathogenic E. coli
  • Non-pathogenic E. coli
• Escherichia Coli Strain Market, By End User:
  • Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others
• Escherichia Coli Strain Market, By Geography:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Novozymes A/S
  • QIAGEN N.V.
  • Promega Corporation
  • Agilent Technologies, Inc.
  • New England Biolabs, Inc.
  • Takara Bio Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Sanofi
  • Xiamen Innovax Biotech Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Strain Type
  • Market Snippet, By Application
  • Market Snippet, By Pathogenicity
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Biotechnology research is expected to drive the market growth over forecast period
  • Restraints
• Safety and biosecurity concerns is expected to hinder the market growth over forecast period
  • Opportunities
• Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions, and Collaborations

4. Escherichia Coli Strain Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Escherichia Coli Strain Market, By Strain Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Commensal strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diarrheal strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Extraintestinal pathogenic strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Uropathogenic strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neonatal meningitis strains
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Escherichia Coli Strain Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Production of recombinant proteins
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Quality control organisms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Escherichia Coli Strain Market, By Pathogenicity, 20218-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%) Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pathogenic E. coli
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Non-pathogenic E. coli
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Escherichia Coli Strain Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Escherichia Coli Strain Market, By Geography, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Thermo Fisher Scientific Inc.
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Merck KGaA
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Novozymes A/S
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • QIAGEN N.V.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Promega Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Agilent Technologies, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • New England Biolabs, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Takara Bio Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Bio-Rad Laboratories, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • GenScript Biotech Corporation
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Sanofi
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Xiamen Innovax Biotech Co., Ltd
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

11. Section

• References
• Research Methodology
• About us